Skip to content

Artivion AORT Change in fair value of contingent consideration

Change in fair value of contingent consideration at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
-$179K-117%
IAR
Integra LifeSciencesIART
-$1.29M-698%
TFX
TeleflexTFX
-$2.63M-46.6%
Globus Medical logo
Globus MedicalGMED
$6.35M+3,704%
Sana Biotechnology logo
Sana BiotechnologySANA
$10.75M+476%
LivaNova logo
LivaNovaLIVN
$10.66M+1,056%

Other financials

Income statement

See full
Revenue$116.3M+17.5%
Gross profit$75.4M+18.7%
Operating income$5.8M+170%
Net income$1.4M+381%
EPS (diluted)$0.03+400%

Balance sheet

See full
Cash & equivalents$55.8M+47.9%
Total debt$258.2M-28.8%
Total equity$450.5M+53.1%
Total assets$883.2M+11.6%

Cash flow

See full
Operating cash flow$1.2M+107%
CapEx$8.0M+120%
Free cash flow-$6.8M+66.7%

Valuation

See full
Market cap$1.1B-22.7%
Enterprise value$1.3B-25.5%
P/E94.1×
P/S2.4×-1.3×

Profitability

See full
Gross margin64.6%+0.6pp
Operating margin8.2%+4.1pp
Net margin2.5%+1.5pp
FCF margin-0.1%-2.5pp

Returns & leverage

See full
Return on equity3.1%+1.8pp
Debt / equity0.6×-0.7×
Current ratio3.9×-1.7×

Where this comes from

Reported directly by Artivion in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artivion's change in fair value of contingent consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artivion's change in fair value of contingent consideration?
Artivion (AORT) reported change in fair value of contingent consideration of $1.74M in Q1 2026.
How has Artivion's change in fair value of contingent consideration changed year-over-year?
Artivion's change in fair value of contingent consideration increased by 161.5% year-over-year, from -$2.83M to $1.74M.
What is the long-term trend for Artivion's change in fair value of contingent consideration?
Over 3 years (2021 to 2025), Artivion's change in fair value of contingent consideration has grown at a -4.6% compound annual growth rate (CAGR), from $8.87M to $7.7M.
What does change in fair value of contingent consideration mean?
This represents the non-cash adjustment to the fair value of liabilities related to acquisition-based earn-outs or contingent payments. Changes in this value reflect management's updated expectations regarding the achievement of performance milestones by acquired entities. It is a key indicator of the financial impact of post-acquisition performance relative to initial deal projections.